During his speech last month to a joint session of Congress, President Trump called out the U.S. Food and Drug Administration for its “slow and burdensome approval process.” Those comments came on the heels of Trump’s...more
3/30/2017
/ Budget Cuts ,
Drug Approvals ,
Federal Budget ,
Food and Drug Administration (FDA) ,
Health & Safety Standard ,
Life Sciences ,
Medical Devices ,
Medical Research ,
OMB ,
Pharmaceutical Industry ,
Prescription Drugs ,
Trump Administration ,
User Fees